September 28th, 2022
Media contact: email@example.com
Hannah Davis, one of the co-founders of the Patient-Led Research Collaborative (PLRC) and a board member of Body Politic (BP), has been named to TIME100 Next – Time’s list of the next 100 most influential people in the world. Her entry was written by Senator Tim Kaine.
Since April 2020, Hannah has worked alongside PLRC and BP to create and strengthen research into Long Covid and other viral-onset conditions like ME/CFS, translated Long Covid biomedical research into public communication through social media, and advocated for policies that support people with Long Covid. Her co-authored papers on Long Covid are widely cited, she has regularly advised the CDC, WHO, NIH and others, and in July 2022 she testified before the Select Subcommittee on the Coronavirus Crisis to call for specific research and policy changes around Long Covid.
PLRC is thrilled that Hannah’s efforts to advance research into Long Covid, ME/CFS, and related illnesses is being recognized on the global stage and hopes that this results in more awareness of viral-onset conditions and support for patient-led initiatives. The recognition is a testament to the community of people with Long Covid and ME/CFS who brought light to the illness and continue to fight for better research, resources, and treatment.
To support Hannah’s work and support others with Long Covid, please donate to the Patient-Led Research Collaborative or Body Politic. We also welcome volunteers with a strong background in organization funding or communications. More information on PLRC’s initiatives can be found at http://patientledresearch.com/ and our mailing list sign up is here.
An expansion of the TIME100 list of the most influential people in the world, TIME100 Next highlights 100 emerging leaders who are shaping the future of business, entertainment, sports, politics, health, science and activism, and more. The full list and related tributes appear in the Oct. 10 / Oct. 17 issue of TIME, available on newsstands on Friday, Sept. 30, and now at time.com/next.
Follow @TIME for updates about the list. #TIME100NEXT
About Patient-Led Research Collaborative: Patient-Led Research Collaborative (PLRC) is a multi-diPatient-Led Research Collaborative (PLRC) is a multi-disciplinary group of people with lived experience of Long COVID, formed together in April 2020 through the Body Politic COVID-19 Support Group, and were the first to conduct research on Long COVID. PLRC’s work thus far has resulted in the identification of key symptoms, timeline, comorbidities, and possible treatment options for Long COVID, as well as a $5 million grant for biomedical research with awards decided by patients, a publication of patient-generated hypotheses, and research into the impact of reinfections, identifying Long Covid phenotypes, Long Covid impact in LMIC countries, and others. They have presented their work to the World Health Organization, United States House of Representatives, National Institutes of Health, and Centers for Disease Control and Prevention, and have influenced Long COVID clinical guidelines and legislation. For more on PLRC, visit patientledresearch.com.